Clinical AI agents making triage, diagnostic, and treatment recommendations operate under the strictest accountability requirements of any software category. HIPAA audit controls, FDA SaMD guidance, EU Medical Device Regulation, and EU AI Act Article 12 all apply — simultaneously. Vendor-hosted logs do not satisfy any of them independently.
EU AI Act Annex III — healthcare AI is explicitly listed as high-risk. Article 12 enforcement: August 2, 2026. FDA April 2, 2026 Purolea Cosmetics warning letter cited AI overreliance / lack of human oversight as a cGMP deficiency — "show me how this was generated, and who reviewed it" is now the inspection question.
REGULATORY OBLIGATIONS
HIPAA
Active · US
Section 164.312(b) — audit controls
Audit controls are required for all systems containing ePHI. Every clinical AI decision that touches protected health information must be logged in a tamper-evident format with access tracking. HIPAA OCR penalty tiers: $137–$2.1M per violation category. Self-hosted logs satisfy the letter; cryptographic public-chain logs satisfy the spirit.
FDA SaMD
Active · US
Software as Medical Device guidance
AI/ML-based SaMD must log algorithm inputs, outputs, and model version at every inference. FDA expects post-market surveillance evidence from production decision logs — not aggregated statistics.
EU AI Act
Aug 2 2026 / Dec 2 2027*
Article 12 — record-keeping (Annex III high-risk)
Medical AI is Annex III high-risk by default. Requires structured, exportable, defensible logs — not vendor-hosted records. Penalty: 3% of global annual turnover or €15M. Enforcement date legally operative August 2, 2026.
EU MDR / IVDR
Active · EU
Annex I — essential safety requirements
EU Medical Device Regulation requires post-market clinical follow-up and traceability for AI-assisted diagnostics. Audit logs must be available to Notified Bodies and competent authorities on request.
* EU AI Act Annex III enforcement date: August 2, 2026 (legally operative). EU Digital Omnibus provisional agreement (May 7, 2026) proposes extending to December 2, 2027 — not yet formally enacted. Prepare for the earlier date.
HOW YOLO SATISFIES IT · PRIMITIVE → REQUIREMENT
PRIMITIVE
REQUIREMENT SATISFIED
AUDIT CHAIN
HIPAA 164.312(b) · FDA SaMD post-market surveillance
Every clinical recommendation logged as an append-only entry with SHA-256 linkage. The chain cannot be edited — not by the health system, the AI vendor, or Yolo. HIPAA auditors and FDA reviewers can access directly.
IDENTITY REGISTRY
Model version traceability · accountable principal
ERC-721 identity per clinical AI agent. Ownership tracks which organization is the responsible principal. Model updates create traceable identity events. Satisfies FDA requirement for documentation of AI/ML version changes in SaMD.
DECISIONAL LOGGING
Per-recommendation audit capture at all tiers
Consequential tier for triage outputs and treatment suggestions. High-stakes tier for diagnostic recommendations with direct therapeutic consequence. IPFS-pinned evidence payloads (model inputs, rationale, confidence scores) on high-stakes events.
AUDIT CHAIN AND IDENTITY REGISTRY ARE LIVE ON BASE MAINNET TODAY.
PRICING · DECISIONAL LOGGING TIERS
ROUTINE
$0.0001 / event
Routine events
CONSEQUENTIAL
$0.01 / event
Consequential events
CLINICAL
$0.10 / event
Clinical events
VOLUME NOTE
Large health system (HCA, Kaiser, Cleveland Clinic tier): ~200 AI agents across radiology, pathology, sepsis prediction, ambient scribes, clinical decision support. Daily volume per agent: 50K routine + 500 consequential + 25 high-stakes. At three-tier pricing: ~$912K/year per health system across 200 agents.
SCALE
$100K–$2.5M/year per large health system. Large IDNs run 500+ AI agents at full deployment. Decisional logging sits on top of existing HIPAA compliance and FDA submission budgets.
WHO BUYS THIS
Epic Systems · Nuance (Microsoft) · Google Health · Merative (IBM) · Philips HealthSuite · GE HealthCare · Siemens Healthineers · Tempus AI · 3M Health Information Systems · Optum (UnitedHealth) · HCA Healthcare · Kaiser Permanente · Mayo Clinic · Stanford Medicine · Cleveland Clinic · Northwell Health · CommonSpirit Health · Mass General Brigham · Tenet Healthcare · Providence Health
WHAT THIS REPLACES
HIPAA OCR resolution agreements: median $1.5M per enforcement action. FDA Warning Letter response: $500K–$5M per remediation. EU AI Act fine at 3%: large hospital system global revenue × 3% exposure. Yolo at ~$912K/year per health system replaces both exposure categories.
ACTIVATION TRIGGER
EU AI Act Article 12 enforcement August 2, 2026 — healthcare AI is explicitly listed as Annex III high-risk. FDA April 2, 2026 Purolea Cosmetics warning letter makes AI overreliance / lack of human oversight enforcement-relevant now. HIPAA OCR audit controls (164.312(b)) are active today.
MULTINATIONAL DEPLOYMENT
Health systems with EU operations face simultaneous HIPAA + EU AI Act Article 12 + EU MDR/IVDR obligations. A single Yolo deployment produces the record-keeping evidence all three frameworks require — covering FDA SaMD post-market surveillance, Notified Body documentation under EU MDR, and APAC regulatory submissions (PMDA Japan, TGA Australia) from the same audit chain.
For Chief Medical Information Officer (CMIO), Chief Clinical Officer, Director of AI Ethics Committee, Director of Clinical Informatics, HIPAA compliance officers, regulatory affairs.